Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17:22–35.

Article  CAS  Google Scholar 

Cherry JD, Esnault CD, Baucom ZH, Tripodis Y, Huber BR, Alvarez VE, et al. Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer’s disease. Acta Neuropathol Commun. 2021;9:86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dickerson BC. Hodges’ frontotemporal dementia. 2nd ed. Cambridge: Cambridge University Press; 2016.

Rösler TW, Tayaranian Marvian A, Brendel M, Nykänen NP, Höllerhage M, Schwarz SC, et al. Four-repeat tauopathies. Prog Neurobiol. 2019;180:101644.

Article  PubMed  Google Scholar 

Murray ME, Kouri N, Lin WL, Jack CR Jr, Dickson DW, Vemuri P. Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias. Alzheimers Res Ther. 2014;6:1.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B, et al. Novel tau filament fold in corticobasal degeneration. Nature. 2020;580:283–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi Y, Zhang W, Yang Y, Murzin AG, Falcon B, Kotecha A, et al. Structure-based classification of tauopathies. Nature. 2021;598:359–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, et al. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry. 2019;24:1112–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pascoal TA, Shin M, Kang MS, Chamoun M, Chartrand D, Mathotaarachchi S, et al. In vivo quantification of neurofibrillary tangles with [(18)F]MK-6240. Alzheimers Res Ther. 2018;10:74.

Article  PubMed  PubMed Central  Google Scholar 

Mueller A, Bullich S, Barret O, Madonia J, Berndt M, Papin C, et al. Tau PET imaging with (18)F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study. J Nucl Med. 2020;61:911–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leuzy A, Smith R, Ossenkoppele R, Santillo A, Borroni E, Klein G, et al. Diagnostic performance of RO948 F 18 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders. JAMA Neurol. 2020;77:955–65.

Article  PubMed  Google Scholar 

Ossenkoppele R, Smith R, Mattsson-Carlgren N, Groot C, Leuzy A, Strandberg O, et al. Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease: a head-to-head comparison against amyloid positron emission tomography and magnetic resonance imaging. JAMA Neurol. 2021;78:961–71.

Article  PubMed  PubMed Central  Google Scholar 

Rowe CC, Doré V, Krishnadas N, Burnham S, Lamb F, Mulligan R, et al. Tau imaging with 18F-MK6240 across the Alzheimer’s disease spectrum. https://www.medrxiv.org/content/10.1101/2022.02.13.22270894v1 (2022).

Therriault J, Pascoal TA, Lussier FZ, Tissot C, Chamoun M, Bezgin G, et al. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging. Nat Aging 2022;2:526–35.

Article  Google Scholar 

Rullmann M, Brendel M, Schroeter ML, Saur D, Levin J, Perneczky RG, et al. Multicenter (18)F-PI-2620 PET for in vivo braak staging of tau pathology in Alzheimer’s disease. Biomolecules. 2022;12:458.

Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, et al. Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy. JAMA Neurol. 2020;77:1408–19.

Article  PubMed  Google Scholar 

Tezuka T, Takahata K, Seki M, Tabuchi H, Momota Y, Shiraiwa M, et al. Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies. Brain Commun 2021;3:fcab190.

Article  PubMed  PubMed Central  Google Scholar 

Leuzy A, Pascoal TA, Strandberg O, Insel P, Smith R, Mattsson-Carlgren N, et al. A multicenter comparison of [(18)F]flortaucipir, [(18)F]RO948, and [(18)F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis. Eur J Nucl Med Mol Imaging. 2021;48:2295–305.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aguero C, Dhaynaut M, Normandin MD, Amaral AC, Guehl NJ, Neelamegam R. et al. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Acta Neuropathol Commun. 2019;7:37.

Article  PubMed  PubMed Central  Google Scholar 

Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, et al. Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. Eur J Nucl Med Mol Imaging. 2019;46:2178–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malarte ML, Nordberg A, Lemoine L. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases. Eur J Nucl Med Mol Imaging. 2021;48:1093–102.

Article  CAS  PubMed  Google Scholar 

Willroider M, Roeber S, Horn AKE, Arzberger T, Scheifele M, Respondek G, et al. Superiority of formalin-fixed paraffin-embedded brain tissue for in vitro assessment of progressive supranuclear palsy tau pathology with [(18) F]PI-2620. Front Neurol. 2021;12:684523.

Article  PubMed  PubMed Central  Google Scholar 

Yap SY, Frias B, Wren MC, Schöll M, Fox NC, Årstad E, et al. Discriminatory ability of next-generation tau PET tracers for Alzheimer’s disease. Brain. 2021;144:2284–90.

Article  PubMed  PubMed Central  Google Scholar 

Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev. 2008;108:1501–16.

Article  CAS  PubMed  Google Scholar 

Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD Sr, et al. (18) F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: a multicenter study. Ann Neurol. 2017;82:622–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Utianski RL, Martin PR, Botha H, Schwarz CG, Duffy JR, Petersen RC, et al. Longitudinal flortaucipir ([(18)F]AV-1451) PET imaging in primary progressive apraxia of speech. Cortex. 2020;124:33–43.

Article  PubMed  Google Scholar 

Marquié M, Normandin MD, Meltzer AC, Siao Tick Chong M, Andrea NV, Antón-Fernández A. et al. Pathological correlations of [F-18]-AV-1451 imaging in non-Alzheimer tauopathies. Ann Neurol. 2017;81:117–28.

Article  PubMed  PubMed Central  Google Scholar 

Kuang G, Murugan NA, Zhou Y, Nordberg A, Ågren H. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils. ACS Chem Neurosci. 2020;11:900–8.

Article  CAS  PubMed  Google Scholar 

Murugan NA, Chiotis K, Rodriguez-Vieitez E, Lemoine L, Ågren H, Nordberg A. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging. Eur J Nucl Med Mol Imaging. 2019;46:1369–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murugan NA, Nordberg A, Ågren H. Different positron emission tomography tau tracers bind to multiple binding sites on the tau fibril: insight from computational modeling. ACS Chem Neurosci. 2018;9:1757–67.

Article  CAS  PubMed  Google Scholar 

Zhou Y, Li J, Nordberg A, Ågren H. Dissecting the binding profile of PET tracers to corticobasal degeneration tau fibrils. ACS Chem Neurosci. 2021;12:3487–96.

Article  CAS  PubMed  Google Scholar 

Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, et al. Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue. Acta Neuropathol Commun. 2015;3:40.

Article  PubMed  PubMed Central  Google Scholar 

Gillberg PG, Jossan SS, Askmark H, Aquilonius SM. Large-section cryomicrotomy for in vitro receptor autoradiography. J Pharmacol Methods. 1986;15:169–80.

Article  CAS  PubMed  Google Scholar 

Kumar A, Koistinen NA, Malarte M-L, Nennesmo I, Ingelsson M, Ghetti B, et al. Astroglial tracer BU99008 detects multiple binding sites in Alzheimer’s disease brain. Mol Psychiatry. 2021;26:5833–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg P-G, Nordberg A. Cortical laminar tau deposits and activated astrocytes in Alzheimer’s disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography. Sci Rep. 2017;7:45496.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim C, Haldiman T, Kang SG, Hromadkova L, Han ZZ, Chen W, et al. Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease. Sci Transl Med. 2022;14:eabg0253.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A, et al. Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain. 2017;140:3329–45.

Article  PubMed  PubMed Central